Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response

Biomaterials

Volumn 32, Issue 26, 2011, Pages 6254-6263

  Noh, Young Woock ^a,b   Jang, Yong Suk ^b   Ahn, Kook Jin ^c   Lim, Yong Taik ^d   Chung, Bong Hyun ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chonbuk National University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Antigen delivery; Dendritic cells; Dual modality imaging; Immunity; Polymer nanoparticles

Indexed keywords

ANTIGEN DELIVERY; DENDRITIC CELLS; DUAL-MODALITY IMAGING; IMMUNITY; POLYMER NANOPARTICLES;

ANTIGENS; BODY FLUIDS; CYTOLOGY; EMULSIFICATION; FLOW CYTOMETRY; INFRARED DEVICES; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAMMALS; NANOMAGNETICS; NANOPARTICLES; RESONANCE;

CELLS;

B7 ANTIGEN; CD86 ANTIGEN; CONTRAST MEDIUM; INDOCYANINE GREEN; INTERCELLULAR ADHESION MOLECULE 1; IRON OXIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NANOPARTICLE; OVALBUMIN; POLYMER;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL ADHESION; CELL HOMING; CELL MIGRATION; CROSS PRESENTATION; CYTOPLASM; DENDRITIC CELL; EMULSION; FLOW CYTOMETRY; FLUORESCENCE IMAGING; HYBRIDOMA; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LYMPHATIC DRAINAGE; LYSOSOME; MALE; MOUSE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPERATURE;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; INDOCYANINE GREEN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NANOPARTICLES; OVALBUMIN; POLYMERS; T-LYMPHOCYTES;

MUS;

EID: 79959895629     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.013     Document Type: Article

References (49)

1. Yih T.C., Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 2006, 97(6):1184-1190.
2. Singh M., O'Hagan D.T. Recent advances in vaccine adjuvants. Pharm Res 2002, 19(6):715-728.
3. Doiron A.L., Homan K.A., Emelianov S., Brannon-Peppas L. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharm Res 2009, 26(3):674-682.
4. Park K., Kim S., Kim J.H., Jeon O., Kwon I.C. Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm 2009, 71(3):420-430.
5. Saravanakumar G., Kim K., Park J.H., Rhee K., Kwon I.C. Current status of nanoparticle-based imaging agents for early diagnosis of cancer and atherosclerosis. J Biomed Nanotechnol 2009, 5(1):20-35.
6. Park K., Kim K., Kim J.H., Park H., Kim Y.S., Park K., et al. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. J Control Release 2010, 146(2):219-227.
7. Labhasetwar V., Vasir J.K. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 2007, 59(8):718-728.
8. Gamvrellis A., Leong D., Hanley J.C., Xiang S.D., Mottram P., Plebanski M. Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 2004, 82(5):506-516.
9. Gilboa E. DC-based cancer vaccines. Eur J Clin Invest 2007, 117(5):1195-1203.
10. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
11. Figdor C.G., de Vries I.J., Lesterhuis W.J., Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat Med 2004, 10(5):475-480.
12. Coester C., Nayyar P., Samuel J. In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation. Eur J Pharm Biopharm 2006, 62(3):306-314.
13. Copland M.J., Baird M.A., Rades T., McKenzie J.L., Becker B., Reck F., et al. Liposomal delivery of antigen to human dendritic cells. Vaccine 2003, 21(9-10):883-890.
14. Lutsiak M.E.C., Robinson D.R., Coester C., Kwon G.S., Samuel J. Analysis of poly(D, L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res 2002, 19(10):1480-1487.
15. Thiele L., Rothen-Rutishauser B., Jilek S., Wunderli-Allenspach H., Merkle H.P., Walter E. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?. J Control Release 2001, 76(1-2):59-71.
16. Uto T., Wang X., Sato K., Haraguchi M., Akagi T., Akashi M., et al. Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 2007, 178(5):2979-2986.
17. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005, 5(4):296-306.
18. Noh Y.W., Lim Y.T., Chung B.H. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J 2008, 22(11):3908-3918.
19. Zhang Z., Tongchusak S., Mizukami Y., Kang Y.J., Ioji T., Touma M., et al. Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials 2011, 32(14):3666-3678.
20. Hamdy S., Elamanchili P., Alshamsan A., Molavi O., Satou T., Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D, L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A 2007, 81(3):652-662.
21. Solbrig C.M., Saucier-Sawyer J.K., Cody V., Saltzman W.M., Hanlon D.J. Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells. Mol Pharm 2007, 4(1):47-57.
22. Elamanchili P., Lutsiak C.M., Hamdy S., Diwan M., Samuel J. Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. J Immunother 2007, 30(4):378-395.
23. Han R., Zhu J., Yang X., Xu H. Surface modification of poly(D, L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells. J Biomed Mater Res A 2011, 96(1):142-149.
24. Yoshida M., Babensee J.E. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 2004, 71(1):45-54.
25. Waeckerle-Men Y., Groettrup M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Adv Drug Deliv Rev 2005, 57(3):475-482.
26. Bandyopadhyay A., Fine R.L., Demento S., Bockenstedt L.K., Fahmy T.M. The impact of nanoparticle ligand density on dendritic-cell targeted vaccines. Biomaterials 2011, 32(11):3094-3105.
27. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J Drug Target 1998, 6(3):167-174.
28. Neuberger T., Schopf B., Hofmann H., Hofmann M., Von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005, 293(1):483-496.
29. Rao J., Dragulescu-Andrasi A., Yao H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007, 18(1):17-25.
30. Kosaka N., Ogawa M., Choyke P.L., Kobayashi H. Clinical implications of near-infrared fluorescence imaging in cancer. Future Oncol 2009, 5(9):1501-1511.
31. Licha K., Riefke B., Ntziachristos V., Becker A., Chance B., Semmler W. Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization. Photochem Photobiol 2000, 72(3):392-398.
32. Ntziachristos V., Yodh A.G., Schnall M., Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci USA 2000, 97(6):2767-2772.
33. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003, 7(5):626-634.
34. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., Carbone F.R. T-Cell receptor antagonist peptides induce positive selection. Cell 1994, 76(1):17-27.
35. McCorquodale E.M., Colyer C.L. Indocyanine green as a noncovalent, pseudofluorogenic label for protein determination by capillary electrophoresis. Electrophoresis 2001, 22(12):2403-2408.
36. Lim Y.T., Noh Y.W., Han J.H., Cai Q.Y., Yoon K.H., Chung B.H. Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells. Small 2008, 4(10):1640-1645.
37. Park J., An K., Hwang Y., Park J.G., Noh H.J., Kim J.Y., et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3(12):891-895.
38. Frangioni J.V., Tanaka E., Choi H.S., Fujii H., Bawendi M.G. Image-guided oncologic surgery using invisible light: Completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 2006, 13(12):1671-1681.
39. Mora-Huertas C.E., Fessi H., Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010, 385(1-2):113-142.
40. Verdijk P., Aarntzen E.H., Punt C.J., de Vries I.J., Figdor C.G. Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin Biol Ther 2008, 8(7):865-874.
41. Martín-Fontecha A., Lanzavecchia A., Sallusto F. Dendritic cell migration to peripheral lymph nodes. Handb Exp Pharmacol 2009, 188:31-49.
42. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
43. Bhatia S., Edidin M., Almo S.C., Nathenson S.G. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett 2006, 104(1-2):70-75.
44. Visintin A., Mazzoni A., Spitzer J.H., Wyllie D.H., Dower S.K., Segal D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001, 166(1):249-255.
45. Schuler G., Schuler-Thurner B., Steinman R.M. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003, 15(2):138-147.
46. Martín-Fontecha A., Sebastiani S., Höpken U.E., Uguccioni M., Lipp M., Lanzavecchia A., et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003, 198(4):615-621.
47. Okada N., Tsujino M., Hagiwara Y., Tada A., Tamura Y., Mori K., et al. Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens. Br J Cancer 2001, 84(11):1564-1570.
48. Paglia P., Chiodoni C., Rodolfo M., Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996, 183(1):317-322.
49. Wong C., Morse M., Nair S.K. Induction of primary, human antigen - specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides. J Immunother 1998, 21(1):32-40.